Author(s): Sun ShuMin | Wang XueLin | Wu XiuPing | Zhao Ying | Wang Feng | Liu XiaoLei | Song YanXia | Wu ZhiLiang | Liu MingYuan
Journal: Parasites & Vectors
ISSN 1756-3305
Volume: 4;
Issue: 1;
Start page: 186;
Date: 2011;
Original page
Keywords: Toll Like Receptors | Helminth | Inflammatory Bowel Disease
ABSTRACT
Abstract Helminth infection may modulate the expression of Toll like receptors (TLR) in dendritic cells (DCs) and modify the responsiveness of DCs to TLR ligands. This may regulate aberrant intestinal inflammation in humans with helminthes and may thus help alleviate inflammation associated with human inflammatory bowel disease (IBD). Epidemiological and experimental data provide further evidence that reducing helminth infections increases the incidence rate of such autoimmune diseases. Fine control of inflammation in the TLR pathway is highly desirable for effective host defense. Thus, the use of antagonists of TLR-signaling and agonists of their negative regulators from helminths or helminth products should be considered for the treatment of IBD.
Journal: Parasites & Vectors
ISSN 1756-3305
Volume: 4;
Issue: 1;
Start page: 186;
Date: 2011;
Original page
Keywords: Toll Like Receptors | Helminth | Inflammatory Bowel Disease
ABSTRACT
Abstract Helminth infection may modulate the expression of Toll like receptors (TLR) in dendritic cells (DCs) and modify the responsiveness of DCs to TLR ligands. This may regulate aberrant intestinal inflammation in humans with helminthes and may thus help alleviate inflammation associated with human inflammatory bowel disease (IBD). Epidemiological and experimental data provide further evidence that reducing helminth infections increases the incidence rate of such autoimmune diseases. Fine control of inflammation in the TLR pathway is highly desirable for effective host defense. Thus, the use of antagonists of TLR-signaling and agonists of their negative regulators from helminths or helminth products should be considered for the treatment of IBD.